From my read of the markets, I do believe that there have been...

From my read of the markets, I do believe that there have been some punters on AT1 that were expecting some larger news on the quarterly. However, given that such news did not satisfy those punters, they either wanted to or were forced to sell down their AT1 holdings. The issue is that the AT1 buy and sell sides are usually quite thin and therefore there isn't much liquidity. It doesn't take much to move the share price, so this is likely what we are witnessing right now.

From what I can see, there hasn't really been any tangible negative "thing" happening on the Atomo front in the foreseeable future. Perhaps FDA rejecting the FebriDx submission or other non-approvals, but that's all part of the challenges that Atomo's team should be well versed to face. They seem to be well equipped with dealing with such challenges.